Trump’s HHS and NIH are planning to invest $500 million in a killed-whole-virus approach to universal vaccines, including ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...